BLACKSMITH MEDICINES
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology. Over 30% of known enzymes are metalloenzymes, covering all major enzyme classes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases. Metal ions, including magnesium, zinc, iron, manganese and copper, are the essential ingredient in these metalloenzymes.
BLACKSMITH MEDICINES
Social Links:
Industry:
Biotechnology Genetics Life Science
Founded:
2017-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.blacksmithmedicines.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Nginx Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Acrigen Biosciences
Acrigen Biosciences is dedicated to making gene editing safe.
Padlock Therapeutics
Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more.
Replay Therapeutics
Replay Therapeutics develops a hypoimmunogenic iPSC therapeutic platform and redefines gene therapy and genome editing.
Current Employees Featured
Investors List
MP Healthcare Venture Management
MP Healthcare Venture Management investment in Seed Round - Blacksmith Medicines
Evotec
Evotec investment in Seed Round - Blacksmith Medicines
Eli Lilly
Eli Lilly investment in Seed Round - Blacksmith Medicines
Alexandria Venture Investments
Alexandria Venture Investments investment in Seed Round - Blacksmith Medicines
MagnaSci Ventures
MagnaSci Ventures investment in Seed Round - Blacksmith Medicines
Official Site Inspections
http://www.blacksmithmedicines.com
- Host name: 173.172.196.35.bc.googleusercontent.com
- IP address: 35.196.172.173
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Blacksmith Medicines"
About Us - Blacksmith Medicines
About Us Blacksmiths of Modern Medicine For thousands of years, blacksmiths have made critical contributions to society through hard-work and invention by producing items necessary for …See details»
Blacksmith Medicines - Crunchbase Company Profile & Funding
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology. Over 30% of known enzymes are metalloenzymes, covering all major enzyme …See details»
Blacksmith Medicines - LinkedIn
Https://blacksmithmedicines.com 7 Like Comment Share Blacksmith Medicines 484 followers 7mo Report this post ... World Health Organization, WOAH, and EMA are the world’s leading …See details»
Blacksmith Medicines launches with seed funding and a research ...
-Blacksmith Medicines, a spin-out of Forge Therapeutics, is pioneering a novel metalloenzyme chemistry platform to create new immuno-oncology and inflammation medicines - - Research …See details»
Blacksmith Medicines - Products, Competitors, Financials, …
About Blacksmith Medicines. Blacksmith Medicines develops a platform for medicines for immuno-oncology and inflammatory diseases. The platform uses metalloenzyme-targeted …See details»
Blacksmith Medicines to merge with Forge Therapeutics
Jan 3, 2023 Blacksmith Medicines is involved in developing medicines that target metal-dependent enzymes. Blacksmith CEO and co-founder Zachary Zimmerman said: “We are …See details»
Blacksmith Medicines merging with Forge Therapeutics
Jan 3, 2023 Blacksmith Medicines, Inc., and Forge Therapeutics have signed a definitive merger agreement. This will create a biopharma company dedicated to discovering and developing …See details»
Blacksmith Medicines Launches With Seed Funding and a Research ...
SAN DIEGO, Jan. 8, 2021 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), a biotechnology company focused on creating novel medicines for immuno-oncology and …See details»
Blacksmith Medicines and Zoetis Announce Research …
Feb 14, 2024 For further information, please visit the company's website www.BlacksmithMedicines.com and LinkedIn. Media Contact: Amy Conrad Juniper Point …See details»
Blacksmith Medicines announces merger with Forge Therapeutics …
Jan 2, 2023 For further information, please visit the company’s website at www.BlacksmithMedicines.com and follow us on LinkedIn. Blacksmith Media Contact: Amy …See details»
Blacksmith Medicines Announces $3.3M in Funding from NIAID to …
Feb 21, 2024 For further information, please visit the company's website www.BlacksmithMedicines.com and LinkedIn. Media Contact: Amy Conrad Juniper Point …See details»
Blacksmith Medicines Announces Merger With Forge ... - BioSpace
SAN DIEGO, Jan. 2, 2023 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), and Forge Therapeutics (Forge), announce today that the companies have signed a definitive merger …See details»
Blacksmith Medicines Announces $3.3M in Funding from NIAID
Feb 21, 2024 Blacksmith Medicines, Inc. announced the release of $3.3M from its contract with the National Institute of Allergy and Infectious Diseases, part of the National Institutes of …See details»
Blacksmith Medicines announces oncology scientific advisors
Jan 5, 2023 For further information, please visit the company’s website at www.BlacksmithMedicines.com and follow us on LinkedIn. Blacksmith Media Contact: Amy …See details»
BLACKSMITH MEDICINES ANNOUNCES MERGER WITH FORGE …
SAN DIEGO, Jan. 2, 2023 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), and Forge Therapeutics (Forge), announce today that the companies have signed a definitive merger …See details»
Blacksmith Medicines Launches With Seed Funding and a Research ...
SAN DIEGO, Jan. 8, 2021 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), a biotechnology company focused on creating novel medicines for immuno-oncology and …See details»
Technology - Blacksmith Medicines
Technology Blacksmith Medicines has developed a purpose-built platform focused on the discovery and development of small molecule inhibitors of metal-dependent enzymes. Over …See details»
Blacksmith Medicines to Present at the Gordon Research …
Mar 19, 2024 For further information, please visit the company's website www.BlacksmithMedicines.com and LinkedIn. Media Contact: Amy Conrad Juniper Point …See details»
BLACKSMITH MEDICINES ANNOUNCES ONCOLOGY SCIENTIFIC …
Jan 5, 2023 At Blacksmith Medicines, we are developing medicines targeting metal-dependent enzymes. Over 30% of known enzymes are metalloenzymes, covering all major enzyme …See details»